Search

Your search keyword '"Ferman, Tanis J"' showing total 707 results
Start Over Author "Ferman, Tanis J"
707 results on '"Ferman, Tanis J"'

1. Influences of amyloid-β and tau on white matter neurite alterations in dementia with Lewy bodies

Author

Mak, Elijah, Reid, Robert I., Przybelski, Scott A., Lesnick, Timothy G., Schwarz, Christopher G., Senjem, Matthew L., Raghavan, Sheelakumari, Vemuri, Prashanthi, Jack, Jr, Clifford R., Min, Hoon Ki, Jain, Manoj K., Miyagawa, Toji, Forsberg, Leah K., Fields, Julie A., Savica, Rodolfo, Graff-Radford, Jonathan, Jones, David T., Botha, Hugo, St. Louis, Erik K., Knopman, David S., Ramanan, Vijay K., Dickson, Dennis W., Graff-Radford, Neill R., Ferman, Tanis J., Petersen, Ronald C., Lowe, Val J., Boeve, Bradley F., O’Brien, John T., and Kantarci, Kejal

Published
2024
Full Text
View/download PDF

2. Role of GBA variants in Lewy body disease neuropathology

Author

Walton, Ronald L., Koga, Shunsuke, Beasley, Alexandra I., White, Launia J., Griesacker, Teresa, Murray, Melissa E., Kasanuki, Koji, Hou, Xu, Fiesel, Fabienne C., Springer, Wolfdieter, Uitti, Ryan J., Fields, Julie A., Botha, Hugo, Ramanan, Vijay K., Kantarci, Kejal, Lowe, Val J., Jack, Clifford R., Ertekin-Taner, Nilufer, Savica, Rodolfo, Graff-Radford, Jonathan, Petersen, Ronald C., Parisi, Joseph E., Reichard, R. Ross, Graff-Radford, Neill R., Ferman, Tanis J., Boeve, Bradley F., Wszolek, Zbigniew K., Dickson, Dennis W., Ross, Owen A., and Heckman, Michael G.

Published
2024
Full Text
View/download PDF

3. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.

Author

van der Lee, Sven J, Conway, Olivia J, Jansen, Iris, Carrasquillo, Minerva M, Kleineidam, Luca, van den Akker, Erik, Hernández, Isabel, van Eijk, Kristel R, Stringa, Najada, Chen, Jason A, Zettergren, Anna, Andlauer, Till FM, Diez-Fairen, Monica, Simon-Sanchez, Javier, Lleó, Alberto, Zetterberg, Henrik, Nygaard, Marianne, Blauwendraat, Cornelis, Savage, Jeanne E, Mengel-From, Jonas, Moreno-Grau, Sonia, Wagner, Michael, Fortea, Juan, Keogh, Michael J, Blennow, Kaj, Skoog, Ingmar, Friese, Manuel A, Pletnikova, Olga, Zulaica, Miren, Lage, Carmen, de Rojas, Itziar, Riedel-Heller, Steffi, Illán-Gala, Ignacio, Wei, Wei, Jeune, Bernard, Orellana, Adelina, Then Bergh, Florian, Wang, Xue, Hulsman, Marc, Beker, Nina, Tesi, Niccolo, Morris, Christopher M, Indakoetxea, Begoña, Collij, Lyduine E, Scherer, Martin, Morenas-Rodríguez, Estrella, Ironside, James W, van Berckel, Bart NM, Alcolea, Daniel, Wiendl, Heinz, Strickland, Samantha L, Pastor, Pau, Rodríguez Rodríguez, Eloy, DESGESCO (Dementia Genetics Spanish Consortium), EADB (Alzheimer Disease European DNA biobank), IFGC (International FTD-Genomics Consortium), IPDGC (The International Parkinson Disease Genomics Consortium), RiMod-FTD (Risk and Modifying factors in Fronto-Temporal Dementia), Netherlands Brain Bank (NBB), Boeve, Bradley F, Petersen, Ronald C, Ferman, Tanis J, van Gerpen, Jay A, Reinders, Marcel JT, Uitti, Ryan J, Tárraga, Lluís, Maier, Wolfgang, Dols-Icardo, Oriol, Kawalia, Amit, Dalmasso, Maria Carolina, Boada, Mercè, Zettl, Uwe K, van Schoor, Natasja M, Beekman, Marian, Allen, Mariet, Masliah, Eliezer, de Munain, Adolfo López, Pantelyat, Alexander, Wszolek, Zbigniew K, Ross, Owen A, Dickson, Dennis W, Graff-Radford, Neill R, Knopman, David, Rademakers, Rosa, Lemstra, Afina W, Pijnenburg, Yolande AL, Scheltens, Philip, Gasser, Thomas, Chinnery, Patrick F, Hemmer, Bernhard, Huisman, Martijn A, Troncoso, Juan, Moreno, Fermin, Nohr, Ellen A, Sørensen, Thorkild IA, Heutink, Peter, Sánchez-Juan, Pascual, Posthuma, Danielle, GIFT (Genetic Investigation in Frontotemporal Dementia and Alzheimer’s Disease) Study Group, and Clarimón, Jordi

Subjects
DESGESCO, EADB, IFGC, IPDGC, RiMod-FTD, Netherlands Brain Bank, GIFT (Genetic Investigation in Frontotemporal Dementia and Alzheimer’s Disease) Study Group, Acquired Cognitive Impairment, Brain Disorders, Neurodegenerative, Alzheimer's Disease, Dementia, Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD), Neurosciences, Aging, Parkinson's Disease, Genetics, 2.1 Biological and endogenous factors, Neurological, Neurology & Neurosurgery, Clinical Sciences
Abstract

The IPDGC (The International Parkinson Disease Genomics Consortium) and EADB (Alzheimer Disease European DNA biobank) are listed correctly as an author to the article, however, they were incorrectly listed more than once.

Published
2020

4. Research criteria for the diagnosis of prodromal dementia with Lewy bodies

Author

McKeith, Ian G, Ferman, Tanis J, Thomas, Alan J, Blanc, Frédéric, Boeve, Bradley F, Fujishiro, Hiroshige, Kantarci, Kejal, Muscio, Cristina, O'Brien, John T, Postuma, Ronald B, Aarsland, Dag, Ballard, Clive, Bonanni, Laura, Donaghy, Paul, Emre, Murat, Galvin, James E, Galasko, Douglas, Goldman, Jennifer G, Gomperts, Stephen N, Honig, Lawrence S, Ikeda, Manabu, Leverenz, James B, Lewis, Simon JG, Marder, Karen S, Masellis, Mario, Salmon, David P, Taylor, John Paul, Tsuang, Debby W, Walker, Zuzana, Tiraboschi, Pietro, and Group, for the prodromal DLB Diagnostic Study

Subjects
Alzheimer's Disease Related Dementias (ADRD), Acquired Cognitive Impairment, Lewy Body Dementia, Neurodegenerative, Neurosciences, Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD), Mental Health, Aging, Brain Disorders, Dementia, Alzheimer's Disease, Neurological, Humans, Lewy Body Disease, Prodromal Symptoms, prodromal DLB Diagnostic Study Group, Clinical Sciences, Cognitive Sciences, Neurology & Neurosurgery
Abstract

The prodromal phase of dementia with Lewy bodies (DLB) includes (1) mild cognitive impairment (MCI), (2) delirium-onset, and (3) psychiatric-onset presentations. The purpose of our review is to determine whether there is sufficient information yet available to justify development of diagnostic criteria for each of these. Our goal is to achieve evidence-based recommendations for the recognition of DLB at a predementia, symptomatic stage. We propose operationalized diagnostic criteria for probable and possible mild cognitive impairment with Lewy bodies, which are intended for use in research settings pending validation for use in clinical practice. They are compatible with current criteria for other prodromal neurodegenerative disorders including Alzheimer and Parkinson disease. Although there is still insufficient evidence to propose formal criteria for delirium-onset and psychiatric-onset presentations of DLB, we feel that it is important to characterize them, raising the index of diagnostic suspicion and prioritizing them for further investigation.

Published
2020

6. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.

Author

van der Lee, Sven J, Conway, Olivia J, Jansen, Iris, Carrasquillo, Minerva M, Kleineidam, Luca, van den Akker, Erik, Hernández, Isabel, van Eijk, Kristel R, Stringa, Najada, Chen, Jason A, Zettergren, Anna, Andlauer, Till FM, Diez-Fairen, Monica, Simon-Sanchez, Javier, Lleó, Alberto, Zetterberg, Henrik, Nygaard, Marianne, Blauwendraat, Cornelis, Savage, Jeanne E, Mengel-From, Jonas, Moreno-Grau, Sonia, Wagner, Michael, Fortea, Juan, Keogh, Michael J, Blennow, Kaj, Skoog, Ingmar, Friese, Manuel A, Pletnikova, Olga, Zulaica, Miren, Lage, Carmen, de Rojas, Itziar, Riedel-Heller, Steffi, Illán-Gala, Ignacio, Wei, Wei, Jeune, Bernard, Orellana, Adelina, Then Bergh, Florian, Wang, Xue, Hulsman, Marc, Beker, Nina, Tesi, Niccolo, Morris, Christopher M, Indakoetxea, Begoña, Collij, Lyduine E, Scherer, Martin, Morenas-Rodríguez, Estrella, Ironside, James W, van Berckel, Bart NM, Alcolea, Daniel, Wiendl, Heinz, Strickland, Samantha L, Pastor, Pau, Rodríguez Rodríguez, Eloy, DESGESCO (Dementia Genetics Spanish Consortium), EADB (Alzheimer Disease European DNA biobank), EADB (Alzheimer Disease European DNA biobank), IFGC (International FTD-Genomics Consortium), IPDGC (The International Parkinson Disease Genomics Consortium), IPDGC (The International Parkinson Disease Genomics Consortium), RiMod-FTD (Risk and Modifying factors in Fronto-Temporal Dementia), Netherlands Brain Bank (NBB), Boeve, Bradley F, Petersen, Ronald C, Ferman, Tanis J, van Gerpen, Jay A, Reinders, Marcel JT, Uitti, Ryan J, Tárraga, Lluís, Maier, Wolfgang, Dols-Icardo, Oriol, Kawalia, Amit, Dalmasso, Maria Carolina, Boada, Mercè, Zettl, Uwe K, van Schoor, Natasja M, Beekman, Marian, Allen, Mariet, Masliah, Eliezer, de Munain, Adolfo López, Pantelyat, Alexander, Wszolek, Zbigniew K, Ross, Owen A, Dickson, Dennis W, Graff-Radford, Neill R, Knopman, David, Rademakers, Rosa, Lemstra, Afina W, Pijnenburg, Yolande AL, Scheltens, Philip, Gasser, Thomas, Chinnery, Patrick F, Hemmer, Bernhard, Huisman, Martijn A, Troncoso, Juan, Moreno, Fermin, Nohr, Ellen A, Sørensen, Thorkild IA, Heutink, Peter, Sánchez-Juan, Pascual, Posthuma, Danielle, GIFT (Genetic Investigation in Frontotemporal Dementia and Alzheimer’s Disease) Study Group, and Clarimón, Jordi

Subjects
DESGESCO (Dementia Genetics Spanish Consortium), EADB, EADB, IFGC (International FTD-Genomics Consortium), IPDGC, IPDGC, RiMod-FTD, Netherlands Brain Bank, GIFT (Genetic Investigation in Frontotemporal Dementia and Alzheimer’s Disease) Study Group, Alzheimer’s disease, Amyotrophic lateral sclerosis, Dementia with Lewy bodies, Frontotemporal dementia, Longevity, Multiple sclerosis, Neurodegenerative disease, PLCG2, Parkinson’s disease, Phospholipase C Gamma 2, Progressive supranuclear palsy, Alzheimer's disease, Parkinson's disease, Alzheimer's Disease, frontotemporal dementia, dementia with Lewy-bodies, progressive suprauclear palsy, Parkinson's Disease, amyotrophic lateral sclerosis, multiple sclerosis, neurodegenerative disease, longevity, Clinical Sciences, Neurosciences, Neurology & Neurosurgery
Abstract

The genetic variant rs72824905-G (minor allele) in the PLCG2 gene was previously associated with a reduced Alzheimer's disease risk (AD). The role of PLCG2 in immune system signaling suggests it may also protect against other neurodegenerative diseases and possibly associates with longevity. We studied the effect of the rs72824905-G on seven neurodegenerative diseases and longevity, using 53,627 patients, 3,516 long-lived individuals and 149,290 study-matched controls. We replicated the association of rs72824905-G with reduced AD risk and we found an association with reduced risk of dementia with Lewy bodies (DLB) and frontotemporal dementia (FTD). We did not find evidence for an effect on Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) risks, despite adequate sample sizes. Conversely, the rs72824905-G allele was associated with increased likelihood of longevity. By-proxy analyses in the UK Biobank supported the associations with both dementia and longevity. Concluding, rs72824905-G has a protective effect against multiple neurodegenerative diseases indicating shared aspects of disease etiology. Our findings merit studying the PLCγ2 pathway as drug-target.

Published
2019

7. Cross-sectional Associations of β-Amyloid, Tau, and Cerebrovascular Biomarkers With Neurodegeneration in Probable Dementia With Lewy Bodies

Author

Ferreira, Daniel, Przybelski, Scott A, Lesnick, Timothy G, Schwarz, Christopher G, Diaz-Galvan, Patricia, Graff-Radford, Jonathan, Senjem, Matthew L, Fields, Julie A, Knopman, David S, Jones, David T., Savica, Rodolfo, Ferman, Tanis J., Graff-Radford, Neill, Lowe, Val J., Jack, Clifford R., Petersen, Ronald C, Westman, Eric, Boeve, Brad F, and Kantarci, Kejal

Published
2022
Full Text
View/download PDF

8. Mitochondrial genomic variation in dementia with Lewy bodies: association with disease risk and neuropathological measures

Author

Valentino, Rebecca R., Ramnarine, Chloe, Heckman, Michael G., Johnson, Patrick W., Soto-Beasley, Alexandra I., Walton, Ronald L., Koga, Shunsuke, Kasanuki, Koji, Murray, Melissa E., Uitti, Ryan J., Fields, Julie A., Botha, Hugo, Ramanan, Vijay K., Kantarci, Kejal, Lowe, Val J., Jack, Clifford R., Ertekin-Taner, Nilufer, Savica, Rodolfo, Graff-Radford, Jonathan, Petersen, Ronald C., Parisi, Joseph E., Reichard, R. Ross, Graff-Radford, Neill R., Ferman, Tanis J., Boeve, Bradley F., Wszolek, Zbigniew K., Dickson, Dennis W., and Ross, Owen A.

Published
2022
Full Text
View/download PDF

9. Cerebrovascular disease, neurodegeneration, and clinical phenotype in dementia with Lewy bodies

Author

Ferreira, Daniel, Nedelska, Zuzana, Graff-Radford, Jonathan, Przybelski, Scott A., Lesnick, Timothy G., Schwarz, Christopher G., Botha, Hugo, Senjem, Matthew L., Fields, Julie A., Knopman, David S., Savica, Rodolfo, Ferman, Tanis J., Graff-Radford, Neill R., Lowe, Val J., Jack, Clifford R., Petersen, Ronald C., Lemstra, Afina W., van de Beek, Marleen, Barkhof, Frederik, Blanc, Frederic, Loureiro de Sousa, Paulo, Philippi, Nathalie, Cretin, Benjamin, Demuynck, Catherine, Hort, Jakub, Oppedal, Ketil, Boeve, Bradley F., Aarsland, Dag, Westman, Eric, and Kantarci, Kejal

Published
2021
Full Text
View/download PDF

10. Diagnosis and management of dementia with Lewy bodies

Author

McKeith, Ian G, Boeve, Bradley F, Dickson, Dennis W, Halliday, Glenda, Taylor, John-Paul, Weintraub, Daniel, Aarsland, Dag, Galvin, James, Attems, Johannes, Ballard, Clive G, Bayston, Ashley, Beach, Thomas G, Blanc, Frédéric, Bohnen, Nicolaas, Bonanni, Laura, Bras, Jose, Brundin, Patrik, Burn, David, Chen-Plotkin, Alice, Duda, John E, El-Agnaf, Omar, Feldman, Howard, Ferman, Tanis J, Ffytche, Dominic, Fujishiro, Hiroshige, Galasko, Douglas, Goldman, Jennifer G, Gomperts, Stephen N, Graff-Radford, Neill R, Honig, Lawrence S, Iranzo, Alex, Kantarci, Kejal, Kaufer, Daniel, Kukull, Walter, Lee, Virginia MY, Leverenz, James B, Lewis, Simon, Lippa, Carol, Lunde, Angela, Masellis, Mario, Masliah, Eliezer, McLean, Pamela, Mollenhauer, Brit, Montine, Thomas J, Moreno, Emilio, Mori, Etsuro, Murray, Melissa, O'Brien, John T, Orimo, Sotoshi, Postuma, Ronald B, Ramaswamy, Shankar, Ross, Owen A, Salmon, David P, Singleton, Andrew, Taylor, Angela, Thomas, Alan, Tiraboschi, Pietro, Toledo, Jon B, Trojanowski, John Q, Tsuang, Debby, Walker, Zuzana, Yamada, Masahito, and Kosaka, Kenji

Subjects
Brain Disorders, Clinical Research, Acquired Cognitive Impairment, Neurosciences, Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD), Alzheimer's Disease Related Dementias (ADRD), Lewy Body Dementia, Alzheimer's Disease, Prevention, Aging, Dementia, Neurodegenerative, Neurological, Biomarkers, Humans, Lewy Body Disease, Practice Guidelines as Topic, Clinical Sciences, Cognitive Sciences, Neurology & Neurosurgery
Abstract

The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about the clinical and pathologic diagnosis of DLB, updating the previous report, which has been in widespread use for the last decade. The revised DLB consensus criteria now distinguish clearly between clinical features and diagnostic biomarkers, and give guidance about optimal methods to establish and interpret these. Substantial new information has been incorporated about previously reported aspects of DLB, with increased diagnostic weighting given to REM sleep behavior disorder and 123iodine-metaiodobenzylguanidine (MIBG) myocardial scintigraphy. The diagnostic role of other neuroimaging, electrophysiologic, and laboratory investigations is also described. Minor modifications to pathologic methods and criteria are recommended to take account of Alzheimer disease neuropathologic change, to add previously omitted Lewy-related pathology categories, and to include assessments for substantia nigra neuronal loss. Recommendations about clinical management are largely based upon expert opinion since randomized controlled trials in DLB are few. Substantial progress has been made since the previous report in the detection and recognition of DLB as a common and important clinical disorder. During that period it has been incorporated into DSM-5, as major neurocognitive disorder with Lewy bodies. There remains a pressing need to understand the underlying neurobiology and pathophysiology of DLB, to develop and deliver clinical trials with both symptomatic and disease-modifying agents, and to help patients and carers worldwide to inform themselves about the disease, its prognosis, best available treatments, ongoing research, and how to get adequate support.

Published
2017

12. The value of multimodal imaging with 123I-FP-CIT SPECT in differential diagnosis of dementia with Lewy bodies and Alzheimer's disease dementia

Author

Miyagawa, Toji, Przybelski, Scott A., Maltais, Daniela, Min, Hoon-Ki, Jordan, Lennon, Lesnick, Timothy G., Chen, Qin, Graff-Radford, Jonathan, Jones, David, Savica, Rodolfo, Knopman, David, Petersen, Ronald, Kremers, Walter K., Forsberg, Leah K., Fields, Julie A., Ferman, Tanis J., Allen, Laura, Parisi, Joseph, Reichard, R. Ross, Murray, Melissa, Dickson, Dennis, Boeve, Bradley F., Kantarci, Kejal, and Lowe, Val J.

Published
2021
Full Text
View/download PDF

13. FDG PET metabolic signatures distinguishing prodromal DLB and prodromal AD

Author

Kantarci, Kejal, Boeve, Bradley F., Przybelski, Scott A., Lesnick, Timothy G., Chen, Qin, Fields, Julie, Schwarz, Christopher G., Senjem, Matthew L., Gunte, Jeffrey L., Jack, Clifford R., Min, Paul, Jain, Manoj, Miyagawa, Toji, Savica, Rodolfo, Graff-Radford, Jonathan, Botha, Hugo, Jones, David T., Knopman, David S., Graff-Radford, Neill, Ferman, Tanis J., Petersen, Ronald C., and Lowe, Val J.

Published
2021
Full Text
View/download PDF

14. Clinicopathologic Heterogeneity and Glial Activation Patterns in Alzheimer Disease

Author

Kouri, Naomi, primary, Frankenhauser, Isabelle, additional, Peng, Zhongwei, additional, Labuzan, Sydney A., additional, Boon, Baayla D. C., additional, Moloney, Christina M., additional, Pottier, Cyril, additional, Wickland, Daniel P., additional, Caetano-Anolles, Kelsey, additional, Corriveau-Lecavalier, Nick, additional, Tranovich, Jessica F., additional, Wood, Ashley C., additional, Hinkle, Kelly M., additional, Lincoln, Sarah J., additional, Spychalla, A. J., additional, Senjem, Matthew L., additional, Przybelski, Scott A., additional, Engelberg-Cook, Erica, additional, Schwarz, Christopher G., additional, Kwan, Rain S., additional, Lesser, Elizabeth R., additional, Crook, Julia E., additional, Carter, Rickey E., additional, Ross, Owen A., additional, Lachner, Christian, additional, Ertekin-Taner, Nilüfer, additional, Ferman, Tanis J., additional, Fields, Julie A., additional, Machulda, Mary M., additional, Ramanan, Vijay K., additional, Nguyen, Aivi T., additional, Reichard, R. Ross, additional, Jones, David T., additional, Graff-Radford, Jonathan, additional, Boeve, Bradley F., additional, Knopman, David S., additional, Petersen, Ronald C., additional, Jack, Clifford R., additional, Kantarci, Kejal, additional, Day, Gregory S., additional, Duara, Ranjan, additional, Graff-Radford, Neill R., additional, Dickson, Dennis W., additional, Lowe, Val J., additional, Vemuri, Prashanthi, additional, and Murray, Melissa E., additional

Published
2024
Full Text
View/download PDF

16. TDP-43 is associated with a reduced likelihood of rendering a clinical diagnosis of dementia with Lewy bodies in autopsy-confirmed cases of transitional/diffuse Lewy body disease

Author

Buciuc, Marina, Whitwell, Jennifer L., Boeve, Bradley F., Ferman, Tanis J., Graff-Radford, Jonathan, Savica, Rodolfo, Kantarci, Kejal, Fields, Julie A., Knopman, David S., Petersen, Ronald C., Parisi, Joseph E., Murray, Melissa E., Dickson, Dennis W., and Josephs, Keith A.

Published
2020
Full Text
View/download PDF

19. Heritability and genetic variance of dementia with Lewy bodies

Author

Guerreiro, Rita, Escott-Price, Valentina, Hernandez, Dena G., Kun-Rodrigues, Celia, Ross, Owen A., Orme, Tatiana, Neto, Joao Luis, Carmona, Susana, Dehghani, Nadia, Eicher, John D., Shepherd, Claire, Parkkinen, Laura, Darwent, Lee, Heckman, Michael G., Scholz, Sonja W., Troncoso, Juan C., Pletnikova, Olga, Dawson, Ted, Rosenthal, Liana, Ansorge, Olaf, Clarimon, Jordi, Lleo, Alberto, Morenas-Rodriguez, Estrella, Clark, Lorraine, Honig, Lawrence S., Marder, Karen, Lemstra, Afina, Rogaeva, Ekaterina, St. George-Hyslop, Peter, Londos, Elisabet, Zetterberg, Henrik, Barber, Imelda, Braae, Anne, Brown, Kristelle, Morgan, Kevin, Troakes, Claire, Al-Sarraj, Safa, Lashley, Tammaryn, Holton, Janice, Compta, Yaroslau, Van Deerlin, Vivianna, Serrano, Geidy E., Beach, Thomas G., Lesage, Suzanne, Galasko, Douglas, Masliah, Eliezer, Santana, Isabel, Pastor, Pau, Diez-Fairen, Monica, Aguilar, Miquel, Tienari, Pentti J., Myllykangas, Liisa, Oinas, Minna, Revesz, Tamas, Lees, Andrew, Boeve, Brad F., Petersen, Ronald C., Ferman, Tanis J., Graff-Radford, Neill, Cairns, Nigel J., Morris, John C., Pickering-Brown, Stuart, Mann, David, Halliday, Glenda M., Hardy, John, Trojanowski, John Q., Dickson, Dennis W., Singleton, Andrew, Stone, David J., and Bras, Jose

Published
2019
Full Text
View/download PDF

20. Lewy body dementia: Overcoming barriers and identifying solutions

Author

Agarwal, Kanishka, primary, Backler, Wendi, additional, Bayram, Ece, additional, Bloom, Leah, additional, Boeve, Bradley F., additional, Cha, Jang‐Ho, additional, Denslow, Maria, additional, Ferman, Tanis J., additional, Galasko, Douglas, additional, Galvin, James E., additional, Gomperts, Stephen N., additional, Irizarry, Michael C., additional, Kantarci, Kejal, additional, Kaushik, Harsh, additional, Kietlinski, Matt, additional, Koenig, Aaron, additional, Leverenz, James B., additional, McKeith, Ian, additional, McLean, Pamela J., additional, Montine, Thomas J., additional, Moose, Sandra O., additional, O'Brien, John T., additional, Panier, Valery, additional, Ramanathan, Sharad, additional, Ringel, Michael S., additional, Scholz, Sonja W., additional, Small, Jonnell, additional, Sperling, Reisa A., additional, Taylor, Angela, additional, Taylor, John‐Paul, additional, Ward, Rebecca A., additional, Witten, Lisa, additional, and Hyman, Bradley T., additional

Published
2024
Full Text
View/download PDF

21. Longitudinal Free‐Water Changes in Dementia with Lewy Bodies.

Author

Chiu, Shannon Y., Chen, Robin, Wang, Wei‐en, Armstrong, Melissa J., Boeve, Bradley F., Savica, Rodolfo, Ramanan, Vijay, Fields, Julie A., Graff‐Radford, Neill, Ferman, Tanis J., Kantarci, Kejal, and Vaillancourt, David E.

Abstract

Background: Diffusion‐weighted magnetic resonance imaging (dMRI) examines tissue microstructure integrity in vivo. Prior dementia with Lewy bodies (DLB) diffusion tensor imaging studies yielded mixed results. Objective: We employed free‐water (FW) imaging to assess DLB progression and correlate with clinical decline in DLB. Methods: Baseline and follow‐up MRIs were obtained at 12 and/or 24 months for 27 individuals with DLB or mild cognitive impairment with Lewy bodies (MCI‐LB). FW was analyzed using the Mayo Clinic Adult Lifespan Template. Primary outcomes were FW differences between baseline and 12 or 24 months. To compare FW change longitudinally, we included 20 cognitively unimpaired individuals from the Alzheimer's Disease Neuroimaging Initiative. Results: We followed 23 participants to 12 months and 16 participants to 24 months. Both groups had worsening in Montreal Cognitive Assessment (MoCA) and Movement Disorder Society‐Unified Parkinson's Disease Rating Scale (MDS‐UPDRS) scores. We found significant FW increases at both time points compared to baseline in the insula, amygdala, posterior cingulum, parahippocampal, entorhinal, supramarginal, fusiform, retrosplenial, and Rolandic operculum regions. At 24 months, we found more widespread microstructural changes in regions implicated in visuospatial processing, motor, and cholinergic functions. Between‐group analyses (DLB vs. controls) confirmed significant FW changes over 24 months in most of these regions. FW changes were associated with longitudinal worsening of MDS‐UPDRS and MoCA scores. Conclusions: FW increased in gray and white matter regions in DLB, likely due to neurodegenerative pathology associated with disease progression. FW change was associated with clinical decline. The findings support dMRI as a promising tool to track disease progression in DLB. © 2024 International Parkinson and Movement Disorder Society. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

23. Comparative assessment of α‐synuclein seeding activities in the cerebrospinal fluid of MCI patients phenoconverting to DLB

Author

Atik, Merve, primary, Kondru, Naveen Chandra, additional, Savica, Rodolfo, additional, Ramanan, Vijay K, additional, Graff‐Radford, Jonathan, additional, Fields, Julie A., additional, Graff‐Radford, Neill R, additional, Day, Gregory S., additional, Ferman, Tanis J, additional, Forsberg, Leah K., additional, Boeve, Brad F., additional, Kantarci, Kejal, additional, and Ross, Owen A., additional

Published
2023
Full Text
View/download PDF

24. Automated Analysis of REM Sleep without Atonia in the Lewy Body Disease Spectrum

Author

Strainis, Emma P., primary, Jagielski, Jack T., additional, LeClair‐Visonneau, Laurene, additional, Przybelski, Scott A., additional, Feemster, John C, additional, McCarter, Stuart J, additional, Carvalho, Diego Z., additional, Silber, Michael H, additional, Vemuri, Prashanthi, additional, Jack, Clifford R., additional, Miyagawa, Toji, additional, Forsberg, Leah K., additional, Fields, Julie A., additional, Savica, Rodolfo, additional, Graff‐Radford, Jonathan, additional, Jones, David T., additional, Botha, Hugo, additional, Ramanan, Vijay K, additional, Knopman, David S., additional, Graff‐Radford, Neill R, additional, Ferman, Tanis J, additional, Petersen, Ronald C., additional, Lowe, Val J., additional, Boeve, Brad F., additional, Kantarci, Kejal, additional, Dredla, Brynn, additional, and Louis, Erik K St, additional

Published
2023
Full Text
View/download PDF

26. Plasma biomarkers of Alzheimer´s disease in the continuum of dementia with Lewy bodies

Author

Diaz‐Galvan, Patricia, primary, Przybelski, Scott A., additional, Algeciras‐Schimnich, Alicia, additional, Lesnick, Timothy G., additional, Schwarz, Christopher G., additional, Senjem, Matthew L., additional, Gunter, Jeffrey L., additional, Jack, Clifford R., additional, Min, Paul H, additional, Jain, Manoj K., additional, Miyagawa, Toji, additional, Forsberg, Leah K., additional, Fields, Julie A., additional, Savica, Rodolfo, additional, Graff‐Radford, Jonathan, additional, Ramanan, Vijay K, additional, Jones, David T., additional, Botha, Hugo, additional, St. Louis, Erik K, additional, Knopman, David S., additional, Graff‐Radford, Neill R, additional, Ferman, Tanis J, additional, Petersen, Ronald C., additional, Lowe, Val J., additional, Boeve, Brad F., additional, and Kantarci, Kejal, additional

Published
2023
Full Text
View/download PDF

27. Alzheimer’s disease biomarkers of amyloid and tau influence white matter neurite alterations in dementia with Lewy bodies: a NODDI study

Author

Mak, Elijah, primary, Reid, Robert I., additional, Przybelski, Scott A., additional, Lesnick, Timothy G., additional, Schwarz, Christopher G., additional, Senjem, Matthew L., additional, Raghavan, Sheelakumari, additional, Vemuri, Prashanthi, additional, Jack, Clifford R., additional, Min, Hoon‐Ki, additional, Jain, Manoj K., additional, Miyagawa, Toji, additional, Forsberg, Leah K., additional, Fields, Julie A., additional, Savica, Rodolfo, additional, Graff‐Radford, Jonathan, additional, Jones, David T., additional, Botha, Hugo, additional, St. Louis, Erik K, additional, Knopman, David S., additional, Ramanan, Vijay K, additional, Graff‐Radford, Neill R, additional, Ferman, Tanis J, additional, Petersen, Ronald C., additional, Lowe, Val J., additional, Boeve, Brad F., additional, O'Brien, John T, additional, and Kantarci, Kejal, additional

Published
2023
Full Text
View/download PDF

28. Mild Cognitive Impairment at Risk for Lewy Body Dementia

Author

Chen, Qin, Lowe, Val J., Boeve, Bradley F., Przybelski, Scott A., Miyagawa, Toji, Senjem, Matthew L., Jack, Clifford R., Jr, Lesnick, Timothy G., Kremers, Walter K., Fields, Julie A., Min, Hoon-Ki, Schwarz, Christopher G., Gunter, Jeffrey L., Graff-Radford, Jonathan, Savica, Rodolfo, Knopman, David S., Jones, David, Ferman, Tanis J., Graff-Radford, Neill R., Petersen, Ronald C., and Kantarci, Kejal

Published
2021
Full Text
View/download PDF

30. MRI and pathology of REM sleep behavior disorder in dementia with Lewy bodies

Author

Murray, Melissa E, Ferman, Tanis J, Boeve, Bradley F, Przybelski, Scott A, Lesnick, Timothy G, Liesinger, Amanda M, Senjem, Matthew L, Gunter, Jeffrey L, Preboske, Gregory M, Lowe, Val J, Vemuri, Prashanthi, Dugger, Brittany N, Knopman, David S, Smith, Glenn E, Parisi, Joseph E, Silber, Michael H, Graff-Radford, Neill R, Petersen, Ronald C, Jack, Clifford R, Dickson, Dennis W, and Kantarci, Kejal

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Alzheimer's Disease, Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD), Aging, Dementia, Lewy Body Dementia, Acquired Cognitive Impairment, Neurodegenerative, Neurosciences, Sleep Research, Brain Disorders, Clinical Research, Aetiology, 2.1 Biological and endogenous factors, Neurological, Aged, Aged, 80 and over, Amyloid beta-Peptides, Autopsy, Brain, Cohort Studies, Female, Humans, Image Processing, Computer-Assisted, Lewy Body Disease, Likelihood Functions, Magnetic Resonance Imaging, Male, REM Sleep Behavior Disorder, Retrospective Studies, Severity of Illness Index, alpha-Synuclein, tau Proteins, Cognitive Sciences, Neurology & Neurosurgery, Clinical sciences
Abstract

ObjectiveTo determine structural MRI and digital microscopic characteristics of REM sleep behavior disorder in individuals with low-, intermediate-, and high-likelihood dementia with Lewy bodies (DLB) at autopsy.MethodsPatients with autopsy-confirmed low-, intermediate-, and high-likelihood DLB, according to the probability statement recommended by the third report of the DLB Consortium, and antemortem MRI, were identified (n = 75). The clinical history was assessed for presence (n = 35) and absence (n = 40) of probable REM sleep behavior disorder (pRBD), and patients' antemortem MRIs were compared using voxel-based morphometry. Pathologic burdens of phospho-tau, β-amyloid, and α-synuclein were measured in regions associated with early neuropathologic involvement, the hippocampus and amygdala.ResultspRBD was present in 21 patients (60%) with high-likelihood, 12 patients (34%) with intermediate-likelihood, and 2 patients (6%) with low-likelihood DLB. Patients with pRBD were younger, more likely to be male (p ≤ 0.001), and had a more frequent neuropathologic diagnosis of diffuse (neocortical) Lewy body disease. In the hippocampus and amygdala, phospho-tau and β-amyloid burden were lower in patients with pRBD compared with those without pRBD (p < 0.01). α-Synuclein burden did not differ in the hippocampus, but trended in the amygdala. Patients without pRBD had greater atrophy of temporoparietal cortices, hippocampus, and amygdala (p < 0.001) than those with pRBD; atrophy of the hippocampus (p = 0.005) and amygdala (p = 0.02) were associated with greater phospho-tau burdens in these regions.ConclusionPresence of pRBD is associated with a higher likelihood of DLB and less severe Alzheimer-related pathology in the medial temporal lobes, whereas absence of pRBD is characterized by Alzheimer-like atrophy patterns on MRI and increased phospho-tau burden.

Published
2013

31. Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: Associations with clinical severity, glucose metabolism and tau PET

Author

Nedelska, Zuzana, Senjem, Matthew L., Przybelski, Scott A., Lesnick, Timothy G., Lowe, Val J., Boeve, Bradley F., Arani, Arvin, Vemuri, Prashanthi, Graff-Radford, Jonathan, Ferman, Tanis J., Jones, David T., Savica, Rodolfo, Knopman, David S., Petersen, Ronald C., Jack, Clifford R., and Kantarci, Kejal

Published
2018
Full Text
View/download PDF

32. Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study

Author

Guerreiro, Rita, Ross, Owen A, Kun-Rodrigues, Celia, Hernandez, Dena G, Orme, Tatiana, Eicher, John D, Shepherd, Claire E, Parkkinen, Laura, Darwent, Lee, Heckman, Michael G, Scholz, Sonja W, Troncoso, Juan C, Pletnikova, Olga, Ansorge, Olaf, Clarimon, Jordi, Lleo, Alberto, Morenas-Rodriguez, Estrella, Clark, Lorraine, Honig, Lawrence S, Marder, Karen, Lemstra, Afina, Rogaeva, Ekaterina, St George-Hyslop, Peter, Londos, Elisabet, Zetterberg, Henrik, Barber, Imelda, Braae, Anne, Brown, Kristelle, Morgan, Kevin, Troakes, Claire, Al-Sarraj, Safa, Lashley, Tammaryn, Holton, Janice, Compta, Yaroslau, Van Deerlin, Vivianna, Serrano, Geidy E, Beach, Thomas G, Lesage, Suzanne, Galasko, Douglas, Masliah, Eliezer, Santana, Isabel, Pastor, Pau, Diez-Fairen, Monica, Aguilar, Miquel, Tienari, Pentti J, Myllykangas, Liisa, Oinas, Minna, Revesz, Tamas, Lees, Andrew, Boeve, Brad F, Petersen, Ronald C, Ferman, Tanis J, Escott-Price, Valentina, Graff-Radford, Neill, Cairns, Nigel J, Morris, John C, Pickering-Brown, Stuart, Mann, David, Halliday, Glenda M, Hardy, John, Trojanowski, John Q, Dickson, Dennis W, Singleton, Andrew, Stone, David J, and Bras, Jose

Published
2018
Full Text
View/download PDF

33. Retrospective Evaluation of Neuropathologic Proxies of the Minimal Atrophy Subtype Compared With Corticolimbic Alzheimer Disease Subtypes

Author

Boon, Baayla D.C., primary, Labuzan, Sydney A., additional, Peng, Zhongwei, additional, Matchett, Billie J., additional, Kouri, Naomi, additional, Hinkle, Kelly M., additional, Lachner, Christian, additional, Ross, Owen A., additional, Ertekin-Taner, Nilufer, additional, Carter, Rickey E., additional, Ferman, Tanis J., additional, Duara, Ranjan, additional, Dickson, Dennis W., additional, Graff-Radford, Neill R., additional, and Murray, Melissa E., additional

Published
2023
Full Text
View/download PDF

34. An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's disease

Author

Sarro, Lidia, Tosakulwong, Nirubol, Schwarz, Christopher G., Graff-Radford, Jonathan, Przybelski, Scott A., Lesnick, Timothy G., Zuk, Samantha M., Reid, Robert I., Raman, Mekala R., Boeve, Bradley F., Ferman, Tanis J., Knopman, David S., Comi, Giancarlo, Filippi, Massimo, Murray, Melissa E., Parisi, Joseph E., Dickson, Dennis W., Petersen, Ronald C., Jack, Clifford R., Jr., and Kantarci, Kejal

Published
2017
Full Text
View/download PDF

36. Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsy

Author

Strickland, Samantha L., Morel, Hélène, Prusinski, Christian, Allen, Mariet, Patel, Tulsi A., Carrasquillo, Minerva M., Conway, Olivia J., Lincoln, Sarah J., Reddy, Joseph S., Nguyen, Thuy, Malphrus, Kimberly G., Soto, Alexandra I., Walton, Ronald L., Crook, Julia E., Murray, Melissa E., Boeve, Bradley F., Petersen, Ronald C., Lucas, John A., Ferman, Tanis J., Uitti, Ryan J., Wszolek, Zbigniew K., Ross, Owen A., Graff-Radford, Neill R., Dickson, Dennis W., and Ertekin-Taner, Nilüfer

Published
2020
Full Text
View/download PDF

37. Disparate Dementia Risk Factors Are Associated with Cognitive Impairment and Rates of Decline in African Americans.

Author

Lachner, Christian, Craver, Emily C., Babulal, Ganesh M., Lucas, John A., Ferman, Tanis J., White, Richard O., Graff‐Radford, Neill R., and Day, Gregory S.

Subjects
DISEASE risk factors, COGNITION disorders, VITAMIN B12 deficiency, AFRICAN Americans, ALZHEIMER'S disease
Abstract

Objective: This study was undertaken to evaluate the frequency of modifiable dementia risk factors and their association with cognitive impairment and rate of decline in diverse participants engaged in studies of memory and aging. Methods: Modifiable dementia risk factors and their associations with cognitive impairment and cognitive decline were determined in community‐dwelling African American (AA; n = 261) and non‐Hispanic White (nHW; n = 193) participants who completed ≥2 visits at the Mayo Clinic Alzheimer Disease Research Center in Jacksonville, Florida. Risk factors and their associations with cognitive impairment (global Clinical Dementia Rating [CDR] ≥ 0.5) and rates of decline (CDR Sum of Boxes) in impaired participants were compared in AA and nHW participants, controlling for demographics, APOE ɛ4 status, and Area Deprivation Index. Results: Hypertension, hypercholesterolemia, obesity, and diabetes were overrepresented in AA participants, but were not associated with cognitive impairment. Depression was associated with increased odds of cognitive impairment in AA (odds ratio [OR] = 4.30, 95% confidence interval [CI] = 2.13–8.67) and nHW participants (OR = 2.79, 95% CI = 1.21–6.44) but uniquely associated with faster decline in AA participants (β = 1.71, 95% CI = 0.69–2.73, p = 0.001). Fewer AA participants reported antidepressant use (9/49, 18%) than nHW counterparts (57/78, 73%, p < 0.001). Vitamin B12 deficiency was also associated with an increased rate of cognitive decline in AA participants (β = 2.65, 95% CI = 0.38–4.91, p = 0.023). Interpretation: Modifiable dementia risk factors are common in AA and nHW participants, representing important risk mitigation targets. Depression was associated with dementia in AA and nHW participants, and with accelerated declines in cognitive function in AA participants. Optimizing depression screening and treatment may improve cognitive trajectories and outcomes in AA participants. ANN NEUROL 2024;95:518–529 [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

38. β-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies

Author

Ferreira, Daniel, Przybelski, Scott A., Lesnick, Timothy G., Lemstra, Afina W., Londos, Elisabet, Blanc, Frederic, Nedelska, Zuzana, Schwarz, Christopher G., Graff-Radford, Jonathan, Senjem, Matthew L., Fields, Julie A., Knopman, David S., Savica, Rodolfo, Ferman, Tanis J., Graff-Radford, Neill R., Lowe, Val J., Jack, Clifford R., Jr, Petersen, Ronald C., Mollenhauer, Brit, Garcia-Ptacek, Sara, Abdelnour, Carla, Hort, Jakub, Bonanni, Laura, Oppedal, Ketil, Kramberger, Milica G., Boeve, Bradley F., Aarsland, Dag, Westman, Eric, and Kantarci, Kejal

Published
2020
Full Text
View/download PDF

39. Subtypes of dementia with Lewy bodies are associated with α-synuclein and tau distribution

Author

Ferman, Tanis J., Aoki, Naoya, Boeve, Bradley F., Aakre, Jeremiah A., Kantarci, Kejal, Graff-Radford, Jonathan, Parisi, Joseph E., Van Gerpen, Jay A., Graff-Radford, Neill R., Uitti, Ryan J., Pedraza, Otto, Murray, Melissa E., Wszolek, Zbigniew K., Reichard, R. Ross, Fields, Julie A., Ross, Owen A., Knopman, David S., Petersen, Ronald C., and Dickson, Dennis W.

Published
2020
Full Text
View/download PDF

41. β-Amyloid Load on PET Along the Continuum of Dementia With Lewy Bodies

Author

Diaz-Galvan, Patricia, primary, Przybelski, Scott A, additional, Lesnick, Timothy G, additional, Schwarz, Christopher G, additional, Senjem, Matthew L, additional, Gunter, Jeffrey L, additional, Jack, Clifford R., additional, Paul Min, Hoon-Ki, additional, Jain, Manoj, additional, Miyagawa, Toji, additional, Forsberg, Leah K, additional, Fields, Julie A, additional, Savica, Rodolfo, additional, Graff-Radford, Jonathan, additional, Jones, David T., additional, Botha, Hugo, additional, St Louis, Erik K., additional, Knopman, David S, additional, Ramanan, Vijay K, additional, Ross, Owen, additional, Graff-Radford, Neill, additional, Day, Gregory S, additional, Dickson, Dennis W., additional, Ferman, Tanis J., additional, Petersen, Ronald C, additional, Lowe, Val J., additional, Boeve, Brad F, additional, and Kantarci, Kejal, additional

Published
2023
Full Text
View/download PDF

42. MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies

Author

Labbé, Catherine, Heckman, Michael G., Lorenzo-Betancor, Oswaldo, Soto-Ortolaza, Alexandra I., Walton, Ronald L., Murray, Melissa E., Allen, Mariet, Uitti, Ryan J., Wszolek, Zbigniew K., Smith, Glenn E., Kantarci, Kejal, Knopman, David S., Lowe, Val J., Jack, Clifford R., Jr., Ertekin-Taner, Nilüfer, Hassan, Anhar, Savica, Rodolfo, Petersen, Ronald C., Parisi, Joseph E., Maraganore, Demetrius M., Graff-Radford, Neill R., Ferman, Tanis J., Boeve, Bradley F., Dickson, Dennis W., and Ross, Owen A.

Published
2016
Full Text
View/download PDF

43. LRRK2 variation and dementia with Lewy bodies

Author

Heckman, Michael G., Soto-Ortolaza, Alexandra I., Sanchez Contreras, Monica Y., Murray, Melissa E., Pedraza, Otto, Diehl, Nancy N., Walton, Ronald, Labbé, Catherine, Lorenzo-Betancor, Oswaldo, Uitti, Ryan J., van Gerpen, Jay, Ertekin-Taner, Nilüfer, Smith, Glenn E., Kantarci, Kejal, Savica, Rodolfo, Jones, David T., Graff-Radford, Jonathan, Knopman, David S., Lowe, Val J., Jack, Clifford R., Jr., Petersen, Ronald C., Parisi, Joseph E., Rademakers, Rosa, Wszolek, Zbigniew K., Graff-Radford, Neill R., Ferman, Tanis J., Dickson, Dennis W., Boeve, Bradley F., and Ross, Owen A.

Published
2016
Full Text
View/download PDF

45. β-Amyloid PET and neuropathology in dementia with Lewy bodies

Author

Kantarci, Kejal, Lowe, Val J., Chen, Qin, Przybelski, Scott A., Lesnick, Timothy G., Schwarz, Christopher G., Senjem, Matthew L., Gunter, Jeffrey L., Jack, Clifford R., Jr, Graff-Radford, Jonathan, Jones, David T., Knopman, David S., Graff-Radford, Neill, Ferman, Tanis J., Parisi, Joseph E., Dickson, Dennis W., Petersen, Ronald C., Boeve, Bradley F., and Murray, Melissa E.

Published
2020
Full Text
View/download PDF

46. Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies

Author

Orme, Tatiana, Hernandez, Dena, Ross, Owen A., Kun-Rodrigues, Celia, Darwent, Lee, Shepherd, Claire E., Parkkinen, Laura, Ansorge, Olaf, Clark, Lorraine, Honig, Lawrence S., Marder, Karen, Lemstra, Afina, Rogaeva, Ekaterina, St. George-Hyslop, Peter, Londos, Elisabet, Zetterberg, Henrik, Morgan, Kevin, Troakes, Claire, Al-Sarraj, Safa, Lashley, Tammaryn, Holton, Janice, Compta, Yaroslau, Van Deerlin, Vivianna, Trojanowski, John Q., Serrano, Geidy E., Beach, Thomas G., Lesage, Suzanne, Galasko, Douglas, Masliah, Eliezer, Santana, Isabel, Pastor, Pau, Tienari, Pentti J., Myllykangas, Liisa, Oinas, Minna, Revesz, Tamas, Lees, Andrew, Boeve, Brad F., Petersen, Ronald C., Ferman, Tanis J., Escott-Price, Valentina, Graff-Radford, Neill, Cairns, Nigel J., Morris, John C., Pickering-Brown, Stuart, Mann, David, Halliday, Glenda, Stone, David J., Dickson, Dennis W., Hardy, John, Singleton, Andrew, Guerreiro, Rita, and Bras, Jose

Published
2020
Full Text
View/download PDF

50. Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies

Author

Nedelska, Zuzana, Ferman, Tanis J., Boeve, Bradley F., Przybelski, Scott A., Lesnick, Timothy G., Murray, Melissa E., Gunter, Jeffrey L., Senjem, Matthew L., Vemuri, Prashanti, Smith, Glenn E., Geda, Yonas E., Graff-Radford, Jonathan, Knopman, David S., Petersen, Ronald C., Parisi, Joseph E., Dickson, Dennis W., Jack, Clifford R., Jr., and Kantarci, Kejal

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results